Is Addus HomeCare (ADUS) overvalued or fairly valued?

MarketChacha shows Addus HomeCare's valuation in context — a trailing P/E of about 22.2, a forward P/E of about 14.7, a price-to-book of about 1.8 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

Does Addus HomeCare's reported profit turn into cash?

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash. MarketChacha computes this cash-conversion check (1.47×) from reported figures — education, not a rating.

What is Addus HomeCare's revenue?

Addus HomeCare reported revenue of $1.4B for FY2025, with net profit of $95.9M, per official filings.

What is the share price of Addus HomeCare (ADUS)?

Addus HomeCare last traded at $110.27 (-2.7% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

Addus HomeCare

ADUS · NYSE · Healthcare · United States

$110.27-2.7%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 7:29 PM

Snapshot

TickerADUS

ExchangeNYSE

SectorHealthcare

IndustryMedical Care Facilities

CountryUnited States

Employees5,982

HeadquartersFrisco, United States

Market cap$2.1B

P/E (TTM)22.2

P/B1.8

Volume127.74K

Websitewww.addus.com

Filings tracked3

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. Its Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. Its Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company serves federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.

Profile as reported by Yahoo Finance.

Who owns it

Insiders2.8%
Institutions97.2%
Public & other0.0%

414 institutional holders

As reported by Yahoo Finance.

Top holders

Blackrock Inc.16.56%
Capital Research Global Investors8.23%
Vanguard Capital Management LLC4.20%
Dimensional Fund Advisors LP3.99%
Silvercrest Asset Management Group, LLC3.91%
State Street Corporation3.86%
Wasatch Advisors LP3.65%
Geode Capital Management, LLC2.58%

Largest institutional holders, as reported by Yahoo Finance (as of 3/31/2026).

Forensic scorecard

No major accounting red flags in the fundamentals we have — profit is backed by cash and returns look healthy.

Cash conversion1.47×

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash.

Net margin trend5.9% → 6.7%

Margin has held broadly steady over the period — stable profitability.

Growth qualityrev 16% · PAT 24%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $386.7M · EPS 1.76

Est. earnings growth +13.0%

Next fiscal year

Rev $1.6B · EPS 7.48

Est. earnings growth +6.9%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

$87.9552-wk range$124.44

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Market cap

$2.1B

Day change

-2.7%

P/E (TTM)

22.2

Fwd P/E

14.7

P/B

1.8

Beta

0.88

Revenue (FY2025)

$1.4B

Net margin

6.7%

ROE

8.8%

Revenue CAGR (2y)

+15.9%

Profit CAGR (2y)

+23.9%

EPS (FY2025)

5.22

Net profit (FY2025)

$95.9M

Market figures: Delayed · as reported by Yahoo Finance. Financials as reported in company filings.

Ask MarketChacha about ADUS

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$1.4B	$95.9M	5.22	6.7%	8.8%
FY2024	$1.2B	$73.6M	4.23	6.4%	7.6%
FY2023	$1.1B	$62.5M	3.83	5.9%	8.8%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q1	$363.6M	$25.1M	1.36	6.9%
2025Q3	$362.3M	$22.8M	1.24	6.3%
2025Q2	$349.4M	$22.1M	1.20	6.3%
2025Q1	$337.7M	$21.2M	1.16	6.3%
2024Q3	$289.8M	$20.2M	1.10	7.0%
2024Q2	$286.9M	$18.1M	1.10	6.3%
2024Q1	$280.7M	$15.8M	0.97	5.6%
2023Q3	$270.7M	$15.4M	0.95	5.7%
2023Q2	$260.0M	$14.9M	0.91	5.7%
2023Q1	$251.6M	$12.7M	0.78	5.0%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

8-K — Shareholder vote results
SEC6/10/2026material
10-Q — FORM 10-Q
SEC5/5/2026
8-K — Results of operations, Reg FD disclosure, Exhibits
SEC5/4/2026material

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.